CII
HOLX

CR Intrinsic Investors’s Hologic HOLX Stock Holding History

CR Intrinsic Investors’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-400,000
Closed -$8.6M – 89
2014
Q1 		$8.6M Buy
+400,000
New +$8.63M 0.32% 108

Other funds holding HOLX

IC
Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
Relational Investors San Diego, California $840M AUM 0.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CR Intrinsic Investors's HOLX Position: Q2 2014 in Review

CR Intrinsic Investors sold out of Hologic (HOLX) in Q2 2014, closing a stake of 400,000 shares — an estimated $8.6M sold.

CR Intrinsic Investors first reported a position in HOLX in Q1 2014 and held it in 1 quarter. The position peaked at $8.6M in Q1 2014. 335 funds tracked by Wall St. Rank hold HOLX as of Q2 2014.

  • CR Intrinsic Investors reported no remaining Hologic position as of Q2 2014 after selling out during the quarter.
  • CR Intrinsic Investors sold 400,000 Hologic shares in Q2 2014, an estimated $8.6M.
  • CR Intrinsic Investors first reported a position in Hologic in Q1 2014 and held it in 1 quarter.
  • CR Intrinsic Investors's Hologic position peaked at $8.6M in Q1 2014.
  • 335 funds tracked by Wall St. Rank held Hologic as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.